{
  "created_at": "Wed Mar 02 1:18:11 +0000 2022",
  "id_str": "1498795293273321473",
  "full_text": "Pfizer's Covid-19 vaccine was highly effective at reducing the risk of severe disease in children 17 years and younger during the Omicron surge but didn’t work as well at preventing infection, according to a new government study https://t.co/aJMfFpBJRc",
  "display_text_range": [
    0,
    252
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/aJMfFpBJRc",
        "expanded_url": "https://on.wsj.com/36NCBOl",
        "display_url": "on.wsj.com/36NCBOl",
        "indices": [
          229,
          252
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 36,
  "favorite_count": 106,
  "possibly_sensitive": false,
  "original_created_at": "Tue Mar 01 23:00:18 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザーのCovid-19ワクチンは、オミクロン急増時の17歳以下の子どもの重症化リスク低減に高い効果を示したが、感染予防にはそれほど効果がなかったことが、政府の新しい研究により明らかになった https://t.co/aJMfFpBJRc 。"
    },
    {
      "locale": "zh",
      "full_text": "根据一项新的政府研究，辉瑞公司的Covid-19疫苗在减少Omicron激增期间17岁及以下儿童的严重疾病风险方面非常有效，但在预防感染方面的效果并不理想，https://t.co/aJMfFpBJRc"
    },
    {
      "locale": "zh-Hant",
      "full_text": "根據一項新的政府研究，輝瑞公司的Covid-19疫苗在減少Omicron激增期間17歲及以下兒童的嚴重疾病風險方面非常有效，但在預防感染方面的效果並不理想，https://t.co/aJMfFpBJRc"
    }
  ]
}